Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) FCF Margin (2016 - 2025)

Abeona Therapeutics (ABEO) has 13 years of FCF Margin data on record, last reported at 4686.75% in Q2 2025.

  • For Q2 2025, FCF Margin changed N/A year-over-year to 4686.75%; the TTM value through Sep 2025 reached 21008.5%, changed N/A, while the annual FY2023 figure was 1066.86%, 201751.0% up from the prior year.
  • FCF Margin reached 4686.75% in Q2 2025 per ABEO's latest filing, down from 294.74% in the prior quarter.
  • Across five years, FCF Margin topped out at 63216.98% in Q4 2021 and bottomed at 20613.24% in Q4 2022.
  • Average FCF Margin over 4 years is 4009.03%, with a median of 294.74% recorded in 2023.
  • Peak YoY movement for FCF Margin: skyrocketed 6327175bps in 2021, then tumbled -8383022bps in 2022.
  • A 4-year view of FCF Margin shows it stood at 63216.98% in 2021, then tumbled by -133bps to 20613.24% in 2022, then surged by 99bps to 294.74% in 2023, then plummeted by -1490bps to 4686.75% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 4686.75% in Q2 2025, 294.74% in Q2 2023, and 20613.24% in Q4 2022.